The synthesis of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, requires a complex multi-step chemical process. Preliminary routes focused on protein fragment coupling, utilizing solid-phase creation methodologies to build the long amino acid sequence. Subsequent investigation has explored different approaches, includin